Sort
15,273 grants matching “antimicrobial resistance”
Antimicrobial Synergy for Carbapenem-Resistant Enterobacteriaceae
$191,376Thea Brennan-Krohn · Beth Israel Deaconess Medical Center · K08 · FY2019 · AI
New genes involved in cellular responses to quinolone treatment
$191,295Xilin Zhao · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2008 · AI
Evaluation of a microbiota-sparing therapeutic concept for periodontal disease, involving removal of pathogenic Porphyromonas and Fusobacterium
$191,250Julian G Hurdle · Texas A&M University Health Science Ctr · R21 · FY2025 · DE
Impact of nucleotide metabolism on enterococcal antibiotic resistance
$191,250Christopher J Kristich · Medical College Of Wisconsin · R21 · FY2015 · AI
Calprotectin in oral innate immunity
$191,250Mark C Herzberg · University Of Minnesota · R21 · FY2017 · DE
Targeted-delivery of small interference RNA against anthrax
$191,250Mingtao Zeng · Texas Tech University Health Scis Center · R21 · FY2015 · AI
Type II-NDHs in M. tuberculosis respiration and persistence
$191,250Thomas C. Zahrt · Medical College Of Wisconsin · R21 · FY2015 · AI
Pyroptotic Macrophages Traps Against Shigella Infection
$191,250Youssef Aachoui · Univ Of Arkansas For Med Scis · R21 · FY2024 · AI
Functional Role of the Enterococcal Polysaccharide Antigen
$191,250Konstantin V Korotkov · University Of Kentucky · R21 · FY2023 · AI
Redefining fatty acid degradation by Staphylococcus aureus
$191,250Jeffrey Lee Bose · University Of Kansas Medical Center · R21 · FY2020 · AI
Mentoring in Immunometabolic Dysregulation in TB and TB/HIV
$191,195Petros C Karakousis · Johns Hopkins University · K24 · FY2023 · AI
Mentoring in Immunometabolic Dysregulation in TB and TB/HIV
$191,195Petros C Karakousis · Johns Hopkins University · K24 · FY2021 · AI
Mentoring in Immunometabolic Dysregulation in TB and TB/HIV
$191,195Petros C Karakousis · Johns Hopkins University · K24 · FY2020 · AI
Mentoring in Immunometabolic Dysregulation in TB and TB/HIV
$191,195Petros C Karakousis · Johns Hopkins University · K24 · FY2019 · AI
Mentoring in Immunometabolic Dysregulation in TB and TB/HIV
$191,195Petros C Karakousis · Johns Hopkins University · K24 · FY2024 · AI
Vitamin D Inhibition of HIV and M. Tuberculosis Coinfection in Macrophages
$191,194Stephen A Spector · University Of California, San Diego · R21 · FY2010 · AI
Host-Targeted Homoserine Lactone Inhibitor as Adjunctive Antipseudomonal Therapy
$191,073Peter Michael Haggie · University Of California, San Francisco · R21 · FY2015 · AI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia
$191,015Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · K23 · FY2017 · AI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia
$191,015Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · K23 · FY2019 · AI
Mechanisms and implications of fosfomycin resistance in Escherichia coli
$191,000Yohei Doi · University Of Pittsburgh At Pittsburgh · R21 · FY2017 · AI
Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa
$190,969Daniel J Wozniak · Ohio State University · R21 · FY2025 · AI
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome
$190,965Laurel L Lenz · University Of Colorado Denver · R21 · FY2022 · AI
Maltodextrin based antibiotics
$190,894Niren Murthy · University Of California Berkeley · R21 · FY2013 · AI
Molecular evolution of Peptide antibiotics for drug-resistant Gram negative bacteria
$190,845William C. Wimley · Tulane University Of Louisiana · R21 · FY2015 · AI
Vaccine induction of Salmonella-specific Th1 memory cells
$190,810Stephen J McSorley · University Of California At Davis · R21 · FY2025 · AI